Liang Han

ORCID: 0000-0003-0070-5003 · 2 papers in corpus
lab-animal 2021
iScience ·doi:10.1016/j.isci.2021.103400

Emerging evidence suggests that ADP-ribosylation factor like-4c (Arl4c) may be a potential choice for cancer treatment. However, its role in pancreatic cancer, especially in tumor-stroma interactions and drug resistance, is still unknown. I…

2000
·doi:10.1016/s0020-7292(00)85223-6